South Asians are roughly four times more likely than Europeans to develop type 2 diabetes, yet most prevention strategies are based on European populations. This research network—spanning Bangladesh, India, Pakistan, Sri Lanka, the UK, Australia, and Singapore—tracks 150,000 South Asian men and women over four years to identify roughly 6,800 new diabetes cases and 3,100 new cardiovascular events. The team will analyse how diet, physical activity, genes, and environment drive this elevated risk, then test two digital interventions—AI-driven education and gamified behaviour change—against usual care in overweight adults aged 30–60. They also work with the World Health Organization to create computational guidelines for primary care, and evaluate national-scale policy approaches with Sri Lanka’s Health Promotion Bureau. If successful, the programme could deliver scalable, personalised prevention strategies for the 25% of the world’s population who are South Asian, shifting health systems from reactive treatment to targeted, early intervention.
View original technical description
Our Global Health Research Network is a partnership between research intensive organisations in Bangladesh, India, Pakistan, Sri Lanka and the UK, and key collaborators in Australia and Singapore. Our primary ambitions are to: i. improve understanding of the mechanisms underlying the high burden of Type-2 diabetes (T2D) and cardiovascular disease (CVD) in South Asians, and ii. improve prevention and control of these major diseases through personalised, health systems and policy-based interventions, that are scalable, sustainable, effective and equitable. Our research comprises four interconnected themes. Theme 1 (Population health) will determine cardiovascular and metabolic outcomes at 4 years, for the ~150,000 South Asian men and women in our Surveillance study (baseline evaluation 2018-21). Using face-face and electronic methods, we will identify ~6,800 cases of incident T2D, and ~3,100 of incident CVD. We will complete molecular phenotyping of baseline samples, and use the data to investigate how lifestyle (diet and physical activity), environmental, genomic and molecular factors drive the increased risk of T2D and CVD amongst South Asians. Theme 2 (Digital Interventions) will test whether digital intervention with i. AI driven education or ii. gamification for behaviour change reduces weight (primary endpoint) and improves quantitative measures of cardiometabolic health, amongst South Asian men and women aged 30-60 years with overweight or obesity (BMI>23kg/m2), compared to usual care over 2 years. We embed the trial within the Surveillance study (Theme 1), bringing rich baseline data for participants, and evaluation in a wide range of South Asian settings. Theme 3 (Training and care co-ordination) focuses on strengthening primary healthcare systems. We connect health surveillance to computational guidelines, care pathway engines, training and digital health interventions, linking seamlessly with work in Themes 1 and 2. We collaborate with WHO to advance international standards for computational guidelines and decision support, and develop modular digital solutions for care co-ordination and care pathway delivery for T2D and CVD, that are scalable, evidence based, interoperable and generalisable. Theme 4 (Policy and environmental interventions) addresses community- and policy-based actions for health promotion and prevention of T2D and CVD in South Asians. In partnership with Health Promotion Bureau of Sri Lanka, we evaluate ‘whole of society’ approaches to intervention that target the demand and supply-side factors identified through our policy and environmental mapping (Theme 1). Evaluation at national scale will provide powerful evidence to inform future health policy in South Asian settings. Capacity building. The research themes will be supported by a programme of capacity building at our collaborating Centres of Excellence in genetic and environmental epidemiology, as well as in digital health, health systems, health policy and implementation science research. Our programme of global health research will improve understanding of T2D and CVD in South Asians, including underlying mechanisms, approaches to identification of high-risk individuals, and scalable strategies for personalised and community wide prevention and control strategies. Results will contribute to transformational change of health promotion and disease prevention amongst South Asians, who represent ~25% of the world’s population.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know